Target intelligence / Profile preview

Colonic mucosa and enteric nervous system

Molecular classification
Other
01

Overview

The colonic mucosa and enteric nervous system (ENS) represent a complex integrated physiological unit rather than a single molecular target. The colonic mucosa is the innermost tissue layer of the large intestine, consisting of the epithelium, lamina propria, and muscularis mucosae, which together manage nutrient absorption, water transport, and immune barrier functions [PMID: 24907339]. The ENS is an extensive, autonomous network of neurons and glia embedded in the gut wall—often called the 'second brain'—that coordinates peristalsis and local blood flow [PMID: 16496521]. Dysregulation of the bidirectional communication between the mucosa and the ENS is a hallmark of functional gastrointestinal disorders like irritable bowel syndrome (IBS) and organic diseases such as inflammatory bowel disease (IBD) [PMID: 27144618]. While pharmacological agents like prucalopride or linaclotide target specific receptors or channels within these tissues, the term 'Colonic mucosa and enteric nervous system' describes anatomical and functional systems rather than a discrete, druggable protein target.

Other names
Intestinal mucosaEnteric nervous systemENSGut-brain axis componentsIntrinsic nervous system of the gastrointestinal tract
02

Mechanism of action

Drugs interacting with these systems typically modulate neurotransmitter receptors (e.g., 5-HT3, 5-HT4), activate epithelial ion channels (e.g., CFTR, ClC-2), or inhibit inflammatory mediators to regulate motility, secretion, and mucosal healing.

03

Biological functions

Gastrointestinal motilityEpithelial barrier functionFluid and electrolyte transportImmune surveillanceNeurotransmissionSecretory function
04

Disease associations

Inflammatory bowel diseaseIrritable bowel syndromeHirschsprung diseaseChronic idiopathic constipationEnteric neuropathiesUlcerative colitis
05

Safety considerations

Ischemic colitisSevere constipationElectrolyte imbalanceGastrointestinal perforationPotential for systemic neurological side effects
06

Interacting drugs

Prucalopride

6 more in the full profile.

07

Biomarkers

Fecal calprotectinC-reactive proteinIntestinal permeability (lactulose/mannitol ratio)Enteric neuronal density (via biopsy)Chromogranin A

Beyond the preview

Go deeper on Colonic mucosa and enteric nervous system.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Colonic mucosa and enteric nervous system.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call